Harbin Pharmaceutical (SHA:600664) obtained marketing approval from China's drug regulator for its potassium sulfate active pharmaceutical ingredient.
Potassium Sulfate is one of the active pharmaceutical ingredients in Sodium Sulfate, Magnesium Sulfate, and Potassium Sulfate Oral Concentrated Solution, exerting an osmotic laxative effect
Shares of the pharmaceutical company rose nearly 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.